{"changes":[],"country":"US","description":"Protego Biopharma develops small-molecule pharmacological chaperones that restore proper protein folding to treat protein misfolding diseases. It targets patients with conditions including cardiomyopathy and AL amyloidosis. The company was built on the success of tafamidis, an FDA-approved amyloidosis treatment discovered by its cofounders.","domain":"protego.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"biotech|therapeutics","investors":[],"lat":32.716692,"lng":-117.169295,"location":"San Diego CA","name":"Protego Biopharma","rounds":[{"amountQuarantined":false,"amountUsd":130000000,"currency":"USD","date":"2025-12-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"protego-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"protego.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://protego.com"},{"fact":"description","publisher":"protego.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://protego.com"}],"stage":"series-b+","techStack":["TYPO3 CMS","Apache HTTP Server 2.4.58","Linkedin Ads","Linkedin Insight Tag","Loglib","Ubuntu","Google Tag Manager","PHP","apache 2.4.58","jquery 3.6.0","bootstrap 4.6.0"],"totalRaisedUsd":130000000,"updatedAt":"2026-05-07"}